InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the complete record of transactions filed by Mayleben Timothy M, Directeur. Director active across 3 companies, notably Marinus Pharmaceuticals INC. Aggregated, 8 reports have been recorded. Breakdown: 2 buys · 0 sell. Activity tracked since 4 February 2022. The latest transaction was disclosed on 7 February 2025 (Disposition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Directeur, MAYLEBEN TIMOTHY M has 8 filings in total. Across the 8 sampled filings, the period runs from 2016-01-19 to 2025-02-11, with EUR 0 of buys and EUR 2436 of sells, and the most frequent transaction nature is Attribution.